Johnson & Johnson MedTech (J&J MedTech) has introduced the variable angle optimised locking technology (VOLT) distal radius and VOLT proximal humerus 3.5 plating systems.
These systems aim to fill a significant gap in the treatment of common fractures, specifically targeting the wrist and upper arm near the shoulder.
Both systems incorporate precision threaded locking technology, which was first introduced with the VOLT platform in 2024, and are intended to enhance stability, performance, and surgical options while improving efficiency.
Fractures of the distal radius and proximal humerus are prevalent, particularly among adults over 65. Wrist fractures account for nearly 20% of emergency department cases and are the most common upper limb fracture.
Proximal humerus fractures are the third most common fragility fracture, representing nearly 6% of adult cases. The incidence of these fractures is expected to increase as populations age.
The VOLT wrist treatment system was developed in collaboration with the Hand Expert Group within the AO Technical Commission. It is designed to address a variety of fracture types. The system includes the VOLT two-column distal radius rim plate, which features a new shape allowing it to sit more distally to target fragments.
This design results in a less prominent profile in the flexor pollicis longus region, catering to both simple and complex fracture patterns.
The VOLT proximal humerus 3.5 plating system offers advancements in treating upper arm fractures involving the shoulder joint. It provides variable angle locking and more plate length options, enhancing flexibility in surgical procedures.
The plate also includes suture holes for easier suture passage, and the VOLT locking screws are engineered with an atraumatic tip to minimise soft tissue irritation.
Johnson & Johnson MedTech orthopaedics, company group chairman Aldo Denti said: “The VOLT wrist treatment system and VOLT proximal humerus 3.5 plating system are not only a testament to advanced engineering but also reflect a deep understanding of the needs of surgeons and patients.
“These innovations are designed to provide surgeons with the tools necessary to navigate the complexities of upper extremity fractures with confidence.”
Earlier this month, J&J MedTech introduced the Kincise 2 surgical automated system, an automated impactor specifically approved for use in knee and hip revision surgeries. This next-generation device aims to improve the efficiency of surgical procedures.
